Oligonucleotide Enhancing Compound Increases Tricyclo-DNA Mediated Exon-Skipping Efficacy in the Mdx Mouse Model

Oligonucleotide Enhancing Compound Increases Tricyclo-DNA Mediated Exon-Skipping Efficacy in the Mdx Mouse Model

Nucleic acid-based therapeutics hold great promise for the treatment of numerous diseases, including neuromuscular disorders, such as Duchenne muscular dystrophy (DMD). Some antisense oligonucleotide (ASO) drugs have already been approved by the US FDA for DMD, but the potential of this therapy is s...

Full description

Bibliographic Details
Main Authors: Flavien Bizot, Abdallah Fayssoil, Cécile Gastaldi, Tabitha Irawan, Xaysongkhame Phongsavanh, Arnaud Mansart, Thomas Tensorer, Elise Brisebard, Luis Garcia, Rudolph L Juliano, Aurélie Goyenvalle
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cells
Subjects:
antisense oligonucleotides
exon-skipping
endosomal escape
duchenne muscular dystrophy
UNC7938
tricyclo-DNA
Online Access:https://www.mdpi.com/2073-4409/12/5/702

Similar Items

Similar Items